AgingResearch.News

Epoxomicin

Intervention1 paper3 findingsPubChem 11226684ChEBI 42265

  • Cells1

Outcomes

3

Phosphatidylserine

upin human cells1

1 study
  1. Epoxomicin increases phosphatidylserine in human cells.

    “Physiological restoration of proteasome-inhibited RBCs caused accelerated ATP depletion, massive protein aggregation, reduced deformability, hemolysis, and phosphatidylserine exposure”

    Cellsduring physiological restorationerythrocyte

    Proteasome activity maintains red blood cell integrity during storage and restoration · Antioxidants (Basel, Switzerland) · 9 Sep 2026

Phosphatidylserine →

Loss of proteostasis

upin human cells1

1 study
  1. Epoxomicin increases loss of proteostasis in human cells.

    “Physiological restoration of proteasome-inhibited RBCs caused accelerated ATP depletion, massive protein aggregation, reduced deformability, hemolysis, and phosphatidylserine exposure”

    Cellsduring physiological restorationerythrocyte

    Proteasome activity maintains red blood cell integrity during storage and restoration · Antioxidants (Basel, Switzerland) · 9 Sep 2026

Loss of proteostasis →

ATP

downin human cells1

1 study
  1. Epoxomicin decreases ATP in human cells.

    “Proteasome inhibition during storage depleted ATP and altered RBC morphology without immediate oxidative damage.”

    Cellsduring storageerythrocyte

    Proteasome activity maintains red blood cell integrity during storage and restoration · Antioxidants (Basel, Switzerland) · 9 Sep 2026

ATP →

Latest

Nov 2025: 0Dec 2025: 0Jan 2026: 0Feb 2026: 0Mar 2026: 0Apr 2026: 0May 2026: 0Jun 2026: 0Jul 2026: 0Aug 2026: 0Sep 2026: 1Oct 2026: 01